Inducement Stock Options Granted

Kura Oncology Reports Inducement Stock Option Grants for Four New Employees

Kura Oncology (Kura) has reported that the Compensation Committee of the Company’s Board of Directors granted inducement awards consisting of nonstatutory stock options to purchase 48,450 shares of common stock to four new employees under the Company's 2023 Inducement Option Plan. The stock options were approved in accordance with Nasdaq Listing Rule 5635(c)(4). Each option will vest over four years, with 25% vesting on the one-year anniversary of the applicable vesting date and the balance of the underlying shares monthly thereafter over 36 months. The company's stock options are subject to the terms and conditions of the 2023 plan and an applicable stock option agreement covering the grant.

Topics